Fonte: Journal of Surgical Oncology. Unidade: FO
Assuntos: CITOMETRIA DE FLUXO, NEOPLASIAS PENIANAS, LINFÓCITOS T, FATORES DE TRANSCRIÇÃO
ABNT
BARROS, Felipe Dubourcq de et al. Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple-negative breast cancer. Journal of Surgical Oncology, 2024Tradução . . Acesso em: 01 nov. 2024.APA
Barros, F. D. de, Soares, F. A., Guimarães, G. C., Martins, M. R., Marinho, F. da S., & Torres, L. C. (2024). Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple-negative breast cancer. Journal of Surgical Oncology. doi:10.1002/jso.27749NLM
Barros FD de, Soares FA, Guimarães GC, Martins MR, Marinho F da S, Torres LC. Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple-negative breast cancer. Journal of Surgical Oncology. 2024 ;[citado 2024 nov. 01 ]Vancouver
Barros FD de, Soares FA, Guimarães GC, Martins MR, Marinho F da S, Torres LC. Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple-negative breast cancer. Journal of Surgical Oncology. 2024 ;[citado 2024 nov. 01 ]